Hálio Rodrigues-Duarte1,2, Thiemo J A van Nijnatten1,3, Tatiana Khoury1, Hiram Cody1, Stefanie Jacobs1, Maxine S Jochelson4. 1. Department of Radiology, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA. 2. Department of Radiology, Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. 3. Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. 4. Department of Radiology, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA. jochelsm@mskcc.org.
Abstract
PURPOSE: Successful breast-conserving surgery (BCS) followed by radiation therapy (XRT) is dependent on complete removal of the cancer with clear surgical margins, providing survival rates equivalent to those observed following mastectomy. In patients who have cancers presenting with microcalcifications, post lumpectomy mammograms (PLM) prior to radiation (XRT) can be performed to ensure that no cancer has been left behind. The purpose of this study was to assess the benefit of PLM in patients with malignant breast tumors presenting with microcalcifications. METHODS: In this IRB-approved retrospective study, we reviewed medical records for patients with breast cancers presenting with microcalcifications who underwent BCS between February 2008 and June 2013. 198 patients who had a PLM prior to XRT for cancers presenting with microcalcifications were included. RESULTS: Histopathology of the initial lumpectomy revealed invasive carcinoma in 78/198 (39.4%) and DCIS alone in 120/198 (60.6%). 114/198 (58%) patients had negative surgical margins. 7/114 (6%) patients with negative margins had positive PLM and re-excisions that were positive for malignancy: sensitivity 88%, specificity 95%, PPV 58%, NPV 99%. 84/198 patients had positive surgical margins. The diagnostic performance of PLM in this group was: sensitivity 55%, specificity 71%, PPV 66%, NPV 61%. CONCLUSION: PLM plays an important role in the evaluation of patients undergoing breast conservation for breast cancer presenting with microcalcifications. Residual malignancy was detected on positive PLM in 6% of patients with negative margins.
PURPOSE: Successful breast-conserving surgery (BCS) followed by radiation therapy (XRT) is dependent on complete removal of the cancer with clear surgical margins, providing survival rates equivalent to those observed following mastectomy. In patients who have cancers presenting with microcalcifications, post lumpectomy mammograms (PLM) prior to radiation (XRT) can be performed to ensure that no cancer has been left behind. The purpose of this study was to assess the benefit of PLM in patients with malignant breast tumors presenting with microcalcifications. METHODS: In this IRB-approved retrospective study, we reviewed medical records for patients with breast cancers presenting with microcalcifications who underwent BCS between February 2008 and June 2013. 198 patients who had a PLM prior to XRT for cancers presenting with microcalcifications were included. RESULTS: Histopathology of the initial lumpectomy revealed invasive carcinoma in 78/198 (39.4%) and DCIS alone in 120/198 (60.6%). 114/198 (58%) patients had negative surgical margins. 7/114 (6%) patients with negative margins had positive PLM and re-excisions that were positive for malignancy: sensitivity 88%, specificity 95%, PPV 58%, NPV 99%. 84/198 patients had positive surgical margins. The diagnostic performance of PLM in this group was: sensitivity 55%, specificity 71%, PPV 66%, NPV 61%. CONCLUSION: PLM plays an important role in the evaluation of patients undergoing breast conservation for breast cancer presenting with microcalcifications. Residual malignancy was detected on positive PLM in 6% of patients with negative margins.
Entities:
Keywords:
Breast cancer; Breast conservative therapy; Mammography; Radiation therapy
Authors: Jonathan T Whaley; Nataniel H Lester-Coll; Samantha M Morrissey; Abigail B Milby; Wei-Ting Hwang; Robert G Prosnitz Journal: Pract Radiat Oncol Date: 2012-10-16
Authors: Thomas A Buchholz; Mark R Somerfield; Jennifer J Griggs; Souzan El-Eid; M Elizabeth H Hammond; Gary H Lyman; Ginny Mason; Lisa A Newman Journal: J Clin Oncol Date: 2014-04-07 Impact factor: 44.544
Authors: Monica Morrow; Eric A Strom; Lawrence W Bassett; D David Dershaw; Barbara Fowble; Armando Giuliano; Jay R Harris; Frances O'Malley; Stuart J Schnitt; S Eva Singletary; David P Winchester Journal: CA Cancer J Clin Date: 2002 Sep-Oct Impact factor: 508.702
Authors: Cameron D Adkisson; Sarah A McLaughlin; Laura A Vallow; Michael G Heckman; Nancy N Diehl; Sanjay P Bagaria; Nicholas Howe; Tammeza Gibson; Barbara Pockaj Journal: Ann Surg Oncol Date: 2013-08-22 Impact factor: 5.344
Authors: Monica Morrow; Kimberly J Van Zee; Lawrence J Solin; Nehmat Houssami; Mariana Chavez-MacGregor; Jay R Harris; Janet Horton; Shelley Hwang; Peggy L Johnson; M Luke Marinovich; Stuart J Schnitt; Irene Wapnir; Meena S Moran Journal: J Clin Oncol Date: 2016-10-31 Impact factor: 44.544